Literature DB >> 16899848

Lung structure abnormalities, but normal lung function in pediatric bronchiectasis.

Francesca Santamaria1, Silvia Montella, Luigi Camera, Cristiana Palumbo, Luigi Greco, Attilio L Boner.   

Abstract

BACKGROUND: Bronchiectasis is not considered to be uncommon in children anymore. The relationship between pulmonary function and severity of bronchiectasis is still controversial. STUDY
OBJECTIVES: To assess the extent and severity of bronchiectasis through high-resolution CT (HRCT) scan score, and to correlate it with clinical, microbiological, and functional data. PATIENTS AND METHODS: Forty-three white children with HRCT-diagnosed bronchiectasis were studied. Bronchiectasis extent, bronchial wall thickening severity, and bronchial wall dilatation severity were evaluated using the Reiff score. Clinical, microbiological, and spirometry results were related to total HRCT scan score and to subscores as well.
RESULTS: The percentages of affected lobes were as follows: right lower lobe, 65%; middle lobe, 56%; left lower lobe, 51%; right upper lobe, 37%; lingula, 30%; and left upper lobe, 30% (chi(2) = 18.4; p = 0.002). The mean (+/- SEM) HRCT score was 20 +/- 2.6. Total score or subscores of bronchiectasis extent, bronchial wall thickening severity, and bronchial wall dilatation severity were not significantly related to FEV(1) and FVC. Seventy-four percent of patients had asthma. The age at the onset of cough correlated with age at the time of the HRCT scan (p = 0.004) and with the presence of asthma (p = 0.01). Positive findings of deep throat or sputum cultures were found more frequently in atopic patients (p = 0.02) and asthmatic (p < 0.01) patients, and in children who were < 2 years of age at the onset of cough (p < 0.01).
CONCLUSIONS: Normal lung function may coexist with HRCT scan abnormalities and does not exclude damage to the bronchial structure. Pulmonary function is not an accurate method for assessing the severity of lung disease in children with bronchiectasis.

Entities:  

Mesh:

Year:  2006        PMID: 16899848     DOI: 10.1378/chest.130.2.480

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  A review of non-cystic fibrosis pediatric bronchiectasis.

Authors:  Eric J Boren; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 2.  Chronic diseases of lung parenchyma in children: the role of imaging.

Authors:  K Haran Jogeesvaran; Catherine M Owens
Journal:  Pediatr Radiol       Date:  2010-04-30

3.  Surgical treatment of non-cystic fibrosis bronchiectasis in Brazilian children.

Authors:  Cristiano Feijó Andrade; Iury Andrade Melo; Arthur Rodrigo Ronconi Holand; Éverton Franco Silva; Gilberto Bueno Fischer; José Carlos Felicetii
Journal:  Pediatr Surg Int       Date:  2013-10-09       Impact factor: 1.827

Review 4.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

5.  Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study.

Authors:  Marco Maglione; Silvia Montella; Carmine Mollica; Vincenzo Carnovale; Paola Iacotucci; Fabiola De Gregorio; Antonella Tosco; Mariarosaria Cervasio; Valeria Raia; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2017-04-12       Impact factor: 2.638

Review 6.  Recurrent Pneumonia in Children: A Reasoned Diagnostic Approach and a Single Centre Experience.

Authors:  Silvia Montella; Adele Corcione; Francesca Santamaria
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

Review 7.  Monitoring disease progression in childhood bronchiectasis.

Authors:  Kathryn A Ramsey; André Schultz
Journal:  Front Pediatr       Date:  2022-09-16       Impact factor: 3.569

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.